How did MASkargo manage vaccine temperature and sublimation?

Question

Accepted Answer

MASkargo Addressed Vaccine Temperature and Sublimation Challenges Through Careful Planning and Experience

MASkargo, the cargo arm of Malaysia Airlines Bhd, managed the transportation of the initial batch of Pfizer-BioNTech vaccine by meticulously planning procedures and leveraging extensive experience in handling temperature-sensitive biological materials. While the specific technologies employed for temperature control and dry ice sublimation were not detailed, the company emphasised the critical factors of maintaining precise temperatures and ensuring rapid handling due to the vaccine's unique storage requirements. Preparations for this complex operation began as early as August of the previous year, anticipating the vaccine's development and logistical needs.
Pre-emptive Planning and Critical Handling Factors

MASkargo initiated its preparations for the vaccine transport while it was still in the development phase, indicating a proactive approach to logistics. The company identified several key considerations crucial for the vaccine's integrity. These included maintaining specific temperature ranges throughout the journey and accounting for the speed of handling. A significant challenge highlighted was the sublimation rate of dry ice, a common coolant for such vaccines, which requires careful management to ensure its effectiveness and prevent damage.
Expedited Procedures for Field Operations

For on-the-ground operations, time and speed were deemed paramount. Unlike conventional medicines or vaccines, the Covid-19 vaccine requires administration as swiftly as possible after arrival, precluding extended storage for customs clearance procedures. This necessity underscored the importance of coordinated efforts with various agencies, including the Customs Department for documentation, and close collaboration with vaccine manufacturers and freight forwarders to streamline the handover process to the Ministry of Health.
Leveraging Extensive Experience and Training

The successful handling of the vaccine was underpinned by MASkargo's substantial experience in transporting other sensitive biological materials, such as polio and diphtheria vaccines. The company's employees are specifically trained to manage these complex logistical challenges, drawing on years of operational expertise. This established proficiency in vaccine transport provided a strong foundation for managing the new Covid-19 vaccines, with MASkargo also confirming its readiness to handle other vaccine types like Sinovac and AstraZeneca. The specific vaccine shipment originated from Pfizer's plant in Belgium, travelled via Puurs and Leipzig Halle Airport, transited in Singapore, and finally arrived at KLIA.

Reading history

Hide →

This history is cleared when the page is closed.

How did MASkargo manage vaccine temperature and sublimation?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends